LEADER 01576oam  2200433Ia 450 
001 9910698875703321
005 20090508155029.0
035   $a(CKB)5470000002397106
035   $a(OCoLC)320548434
035   $a(EXLCZ)995470000002397106
100   $a20090508d2007      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $einformed consent recommendations for source plasma donors participating in plasmapheresis and immunization programs
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,$d[2007]
215   $ai, 7 pages $cdigital, PDF file
300   $aTitle from PDF title page (viewed on May 8, 2009).
300   $a"June 2007".
300   $aIncludes bibliographical references (p. 7).
517   $aGuidance for industry 
606   $aInformed consent (Medical law)$zUnited States
606   $aBlood donors$xGovernment policy$zUnited States
606   $aPlasmapheresis
606   $aImmunization$zUnited States
615  0$aInformed consent (Medical law)
615  0$aBlood donors$xGovernment policy
615  0$aPlasmapheresis.
615  0$aImmunization
712 02$aCenter for Biologics Evaluation and Research (U.S.)
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698875703321
996   $aGuidance for industry$93434577
997   $aUNINA